Simplex Trading
ABCL icon

Simplex Trading’s AbCellera Biologics ABCL Stock Holding History

Simplex Trading’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$684K Buy
196,100
+102,900
+110% +$370K ﹤0.01% 2913
2025
Q4 		$319K Buy
93,200
+7,700
+9% +$34.4K ﹤0.01% 3750
2025
Q3 		$430K Buy
85,500
+68,700
+409% +$303K ﹤0.01% 4009
2025
Q2 		$57K Buy
16,800
+3,900
+30% +$9.71K ﹤0.01% 5780
2025
Q1 		$28K Buy
12,900
+7,200
+126% +$20.6K ﹤0.01% 6285
2024
Q4 		$16K Sell
5,700
-28,600
-83% -$79.6K ﹤0.01% 6833
2024
Q3 		$89K Buy
34,300
+5,100
+17% +$14.1K ﹤0.01% 5348
2024
Q2 		$86K Sell
29,200
-41,400
-59% -$157K ﹤0.01% 5516
2024
Q1 		$319K Buy
70,600
+3,300
+5% +$16.8K ﹤0.01% 4311
2023
Q4 		$384K Buy
67,300
+34,700
+106% +$161K ﹤0.01% 3965
2023
Q3 		$149K Sell
32,600
-3,200
-9% -$19.5K ﹤0.01% 4662
2023
Q2 		$231K Buy
35,800
+3,900
+12% +$26.6K ﹤0.01% 4134
2023
Q1 		$240K Sell
31,900
-90,000
-74% -$817K ﹤0.01% 4114
2022
Q4 		$1.23M Sell
121,900
-48,600
-29% -$561K ﹤0.01% 2272
2022
Q3 		$1.69M Sell
170,500
-20,700
-11% -$227K ﹤0.01% 2109
2022
Q2 		$2.04M Buy
191,200
+61,300
+47% +$519K ﹤0.01% 1847
2022
Q1 		$1.27M Buy
129,900
+108,700
+513% +$1.03M ﹤0.01% 2622
2021
Q4 		$303K Sell
21,200
-7,000
-25% -$106K ﹤0.01% 4550
2021
Q3 		$579K Buy
28,200
+600
+2% +$10.6K ﹤0.01% 3867
2021
Q2 		$607K Buy
27,600
+27,586
+197,043% +$761K ﹤0.01% 3856
2021
Q1 		$47K Buy
+14
New +$558 ﹤0.01% 6685

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's ABCL Position: Q1 2026 in Review

Simplex Trading opened a new position in AbCellera Biologics (ABCL) in Q1 2026: 201,236 shares worth $702K. The stake represents ﹤0.01% of the portfolio and ranks #2880 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ABCL as recently as Q3 2025.

Simplex Trading first reported a position in ABCL in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.22M in Q4 2021. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Simplex Trading held 201,236 shares of AbCellera Biologics worth $702K as of Q1 2026.
  • AbCellera Biologics was a new Simplex Trading position in Q1 2026.
  • AbCellera Biologics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2880 holding.
  • Simplex Trading first reported a position in AbCellera Biologics in Q1 2021 and has held it in 18 quarters since.
  • Simplex Trading's AbCellera Biologics position peaked at $1.22M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.